Andreas Tiede on Antithrombotic Drugs and Their Role in Cancer Progression and Metastasis
Andreas Tiede, Professor, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation at Hannover Medical School, shared a post by NEJM Group on LinkedIn, adding:
“I wouldn’t treat cancer patients with aspirin — yet —, but it is worthwhile observing the field of antithrombotic drugs affecting cancer progression and metastasis. Anticoagulants like heparin were sometimes reported to have similar effects.”
Quoting NEJM Group‘s post:
“A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
The effects of aspirin on cancer metastasis were first recognized more than 50 years ago. In a seminal study, Gasic and colleagues found that fewer lung metastases developed in mice whose drinking water was supplemented with aspirin than in control mice.
Epidemiologic data support the hypothesis that aspirin prevents cancer, but the design and interpretation of randomized trials have been hampered by a lack of mechanistic understanding.
This is changing. In a recent report, Yang and colleagues describe a previously unrecognized immunosuppressive mechanism that prevents T cells from eliminating cancer metastases.
At the heart of this prometastatic mechanism is a protein called ARHGEF1, which is activated by thromboxane A2 (TXA2), a metabolite of the platelet arachidonic acid pathway. This pathway is inhibited by aspirin through inactivation of cyclooxygenase (COX) enzymes.
Title: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Read the full article on the NEJM.
Read also on Hemostasis Today: Eric Topol on How Low-Dose Aspirin May Help Prevent Cancer Metastasis
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience